Craig Hopkinson
Directeur Technique/Scientifique/R&D chez ALKERMES PLC
Fortune : 3 M $ au 30/04/2024
Postes actifs de Craig Hopkinson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALKERMES PLC | Directeur Technique/Scientifique/R&D | 30/05/2017 | - |
Historique de carrière de Craig Hopkinson
Anciens postes connus de Craig Hopkinson
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ALBIREO PHARMA, INC. | Directeur/Membre du Conseil | 01/12/2022 | 02/03/2023 |
Alkermes, Inc.
 Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Directeur Technique/Scientifique/R&D | 01/05/2017 | 01/01/2020 |
| VERTEX PHARMACEUTICALS INCORPORATED | Directeur Technique/Scientifique/R&D | 01/07/2014 | 01/05/2017 |
Eisai, Inc.
 Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Corporate Officer/Principal | 01/01/2013 | 01/07/2014 |
| President | 01/10/2011 | 01/12/2012 |
Formation de Craig Hopkinson
| University of the Free State | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Irlande | 2 |
| Afrique du Sud | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 3 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| ALKERMES PLC | Health Technology |
| VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
| Entreprise privées | 3 |
|---|---|
Eisai, Inc.
Eisai, Inc. Pharmaceuticals: MajorHealth Technology Eisai, Inc. manufactures pharmaceuticals products. It focuses on neurology, gastrointestinal disorders and oncology critical care. The company was founded in 1995 and is headquartered in Woodcliff Lake, NJ. | Health Technology |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Albireo Pharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel bile acid modulators for the treatment of orphan pediatric liver diseases and gastrointestinal disorders. Its pipeline products include Odevixibat, A3384, and Elobixibat. The company was founded by Jan Peter Mattsson and Per-Göran Gillberg on December 8, 2003 and is headquartered in Boston, MA. | Health Technology |
Alkermes, Inc.
Alkermes, Inc. Pharmaceuticals: MajorHealth Technology Alkermes, Inc. develops and manufactures pharmaceutical products. It offers medicines for the treatment of central nervous system (CNS) diseases. The company was founded by Michael A. Wall, Floyd E. Bloom, Frederick W. K. Brown, Paul R. Schimmel and Alexander G. Rich in 1987 and is headquartered in Waltham, MA. | Health Technology |
- Bourse
- Insiders
- Craig Hopkinson
- Expérience